Why are nanoparticles used in some medicines?

What is a nanoparticle?

A nanoparticle is an extremely small particle, measured at the nanoscale, far smaller than what the eye can see. In medicine, nanoparticles are used to give some treatments specific properties. They may help a medicine move through the body, protect an active ingredient, improve how it dissolves, or control how it is released.

Medicines that use this technology are often called nanomedicines. A nanoparticle can act as a tiny carrier, capsule, coating, or delivery system. Sometimes it carries the active medicine. Sometimes it changes how the medicine travels or how long it stays active.

Nanoparticles used in medicines can include liposomes, lipid nanoparticles, iron-carbohydrate complexes, or polymer- and protein-based particles. “Nanoparticle” is not one single ingredient. It is a broad term for very small structures that behave differently depending on their size, material, surface, and purpose.

Why are nanoparticles used in medicines?

Many medicines face the same challenge: reaching the right place in the body, at the right dose, while limiting unnecessary exposure elsewhere. Nanoparticles can sometimes help by improving solubility, protecting fragile medicines, changing how a drug is distributed, or supporting controlled release.

Nanoparticles may help:

• a poorly soluble medicine dissolve better
• a fragile active ingredient survive long enough to work
• a medicine reach certain tissues more effectively
• control how quickly a medicine is released
• make newer treatments possible, such as some RNA-based therapies

This does not mean nanoparticles automatically make a medicine better. They change how a medicine behaves, and that change must be tested carefully.

One well-known example is lipid nanoparticles, often called LNPs. They can help deliver mRNA, a fragile molecule that would otherwise be broken down quickly. Nanotechnology is also used in some cancer treatments, where certain formulations are designed to improve delivery or reduce exposure to some healthy tissues.

Are nanoparticles in medicines safe?

Safety depends on the specific medicine, not simply on whether it contains nanoparticles.

Regulators do not treat nanotechnology products as automatically safe or unsafe. They assess them based on their properties, intended use, quality, safety, and effectiveness. This matters because nanoparticles can behave differently from larger particles, or from the same active ingredient in a conventional formulation.

When assessing a nanoparticle-based medicine, scientists may look at:

• particle size and size distribution
• the material used
• surface coating and charge
• stability during storage
• how the medicine is released
• how the body absorbs, distributes, and clears it
• whether it may trigger immune or infusion-related reactions

For patients, this means the word “nano” should not be treated as a red flag or a magic label. A nanoparticle-based medicine should be judged by the evidence behind that exact product: its benefits, risks, manufacturing quality, and monitoring.

What could this change for patients?

Most patients will not “feel” that a medicine contains nanoparticles. The treatment may still look familiar: an infusion, injection, capsule, or another standard form. The difference is usually in the formulation, meaning how the active substance is packaged, carried, or released.

In some cases, nanoparticle formulations can make a treatment possible when the active substance is unstable or difficult to dissolve. In others, they may help change how the drug is distributed, which can affect side effects or monitoring.

However, side effects do not disappear simply because a medicine uses nanoparticles. A formulation may reduce some risks while raising other questions, such as infusion reactions, immune responses, storage requirements, or differences between similar products.

For people living with chronic conditions, the practical point is that two medicines with the same active substance may not behave the same way if their formulations are different. This is why healthcare professionals consider both the active ingredient and the formulation.

Why do nanoparticles raise so many questions?

Nanoparticles sit between chemistry, biology, engineering, and medicine. This makes them promising, but also complex. Small changes in size, coating, manufacturing, or storage can affect how a medicine behaves. That is why agencies such as the FDA and EMA have specific guidance for medicines that contain nanomaterials.

There is also a communication issue. Words like “nanotechnology” can sound alarming, especially in contexts such as cosmetics, food packaging, environmental exposure, or online misinformation. In approved medicines, nanoparticles are part of a controlled pharmaceutical formulation that must be studied and manufactured carefully.

A useful way to understand a nanoparticle-based medicine is to ask:

• What is the nanoparticle doing?
• What evidence supports its use?
• What benefits and risks were observed?
• How is the product monitored after approval?

Key takeaway

Nanoparticles in medicines are tiny structures that can help carry, protect, or release active substances in specific ways. They are already used in some treatments and remain an active area of research. Their presence does not automatically make a medicine unsafe, experimental, or superior. What matters is the evidence behind the specific medicine, how it is tested, manufactured, and monitored over time.

If you found this article helpful, feel free to give it a “Like” and share your thoughts and questions with the community in the comments below!

Take care!